title: Vigabatrin therapy in infantile spasms: solving one problem and inducing another?
authors.forename: Gabriele
authors.initials: G
authors.lastname: Wohlrab
authors.forename: Hana
authors.initials: H
authors.lastname: Leiba
authors.forename: Rebekka
authors.initials: R
authors.lastname: Kästle
authors.forename: Gianpaolo
authors.initials: G
authors.lastname: Ramelli
authors.forename: Thomas
authors.initials: T
authors.lastname: Schmitt-Mechelke
authors.forename: Bernhard
authors.initials: B
authors.lastname: Schmitt
authors.forename: Klara
authors.initials: K
authors.lastname: Landau
mesh_terms: D000293:Adolescent; D000927:Anticonvulsants / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008297:Male; D012189:Retrospective Studies; D013036:Spasms, Infantile / Q000188:drug therapy*; D020888:Vigabatrin / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*; D014794:Visual Fields / Q000187:drug effects
chemical_list: D000927:Anticonvulsants; D020888:Vigabatrin